# The RETRAIN Trial Phase 2

> **NCT07197996** · NA · RECRUITING · sponsor: **Firstkind Ltd** · enrollment: 80 (estimated)

## Conditions studied

- Ischaemic Stroke

## Interventions

- **DEVICE:** Intermittent Pneumatic Compression
- **DEVICE:** geko® T3

## Key facts

- **NCT ID:** NCT07197996
- **Lead sponsor:** Firstkind Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07197996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07197996, "The RETRAIN Trial Phase 2". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07197996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*